User: Guest  Login
Title:

Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.

Document type:
Journal Article; Research Support, Non-U.S. Gov't
Author(s):
Ferch, U; Kloo, B; Gewies, A; Pfänder, V; Düwel, M; Peschel, C; Krappmann, D; Ruland, J
Abstract:
Diffuse large B cell lymphoma (DLBCL) is the most common type of lymphoma in humans. The aggressive activated B cell-like (ABC) subtype of DLBCL is characterized by constitutive NF-kappaB activity and requires signals from CARD11, BCL10, and the paracaspase MALT1 for survival. CARD11, BCL10, and MALT1 are scaffold proteins that normally associate upon antigen receptor ligation. Signal-induced CARD11-BCL10-MALT1 (CBM) complexes couple upstream events to IkappaB kinase (IKK)/NF-kappaB activation....     »
Journal title abbreviation:
J Exp Med
Year:
2009
Journal volume:
206
Journal issue:
11
Pages contribution:
2313-20
Language:
eng
Fulltext / DOI:
doi:10.1084/jem.20091167
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/19841089
Print-ISSN:
0022-1007
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX